Search clinical trials for: Insight GS

Total 803 results

EVEREST PESQUISA E DESENVOLVIMENTO LTDA

Not yet recruiting

Safety and Efficacy Evaluation of Insight GS Growing System

Early Onset Scoliosis (EOS)

Brazil
Dascena
National Institute on Alcohol Abuse and Alcoholism (NIAAA); Baystate Health; Cape... and other collaborators

Recruiting

Machine Learning Sepsis Alert Notification Using Clinical Data (HindSight P2)

Sepsis | Septic Shock | Severe Sepsis

United States
Dascena

Not yet recruiting

Unsupervised Machine Learning for Clustering of Septic Patients to Determine Optimal Treatment

Sepsis | Septic Shock | Severe Sepsis
Dascena

Completed

Effect of a Sepsis Prediction Algorithm on Clinical Outcomes

Severe Sepsis
Dascena
University of California, San Francisco

Withdrawn

RCT of Sepsis Machine Learning Algorithm

Sepsis | Septic Shock | Severe Sepsis
Moravian University

Completed

Roll for Intervention - TBI Group Treatment

Communication Disorder, Social

United States
EyeQue Corp.
Eye Boutique Optometry

Completed

Study to Evaluate Visual Acuity Measured With the EyeQue Insight Versus a Standard Eyechart.

Visual Acuity

United States
Gilead Sciences

Active, not recruiting

Study of HBV Therapeutic Vaccines GS-2829 and GS-6779 in Healthy Participants and Participants With Chronic Hepatitis B

Chronic Hepatitis B

Taiwan, New Zealand
Gilead Sciences

Completed

Evaluation of the Safety, Tolerability, Pharmacokinetics, and Activity of GS-9450 in Subjects With Chronic HCV

HCV Infection

United States, Netherlands, Germany
Gilead Sciences

Completed

Safety, Tolerability, Pharmacokinetics and Activity of GS-9450 in Adults With Non-Alcoholic Steatohepatitis (NASH)

Nonalcoholic Steatohepatitis

United States, France
Centre Hospitalier Esquirol

Completed

Insight in Persons Presenting Schizophrenia or Related Troubles During Hospitalization in Psychiatry

Schizophrenia

France
Lunit Inc.
King's College London; The Leeds Teaching Hospitals NHS Trust

Not yet recruiting

Real World Evaluation of Lunit INSIGHT MMG Technology

Breast Cancer | Breast Diseases

United Kingdom
Virginia Polytechnic Institute and State University
Riverain Technologies

Completed

Evaluation of Computer-Aided Lung Nodule Detection Software in Thoracic CT for Riverain Technologies LLC

Lung Cancer

United States
Gilead Sciences

Completed

Safety and Effectiveness Study of an Experimental Topical Ointment (GS-9191) for the Treatment of Genital Warts

Genital Warts

United States
Gilead Sciences
Ono Pharmaceutical Co. Ltd; Galapagos NV

Completed

Study to Assess Safety and Efficacy of Filgotinib, Lanraplenib and Tirabrutinib in Adults With Active Sjogren's Syndrome

Sjogren's Syndrome

United States, Spain, United Kingdom, Poland
Ian M. Paul, MD
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

The Intervention Nurses Start Infants Growing on Healthy Trajectories (INSIGHT) Study (INSIGHT)

Obesity | Infant

United States
University of South Florida

Recruiting

Physical Activity and Quality of Life in Fibrotic Lung Diseases After Initiating Anti-fibrotic Therapy and Pulmonary Rehabilitation (Actigraphy)

Lung Diseases, Interstitial

United States
University of California, Davis
University of California, San Francisco; University of Barcelona

Completed

The Psychobiological Effects of Participation in a One-Month Insight Meditation Retreat

Aging

United States
Gilead Sciences

Completed

Safety and Efficacy of SOF/VEL/VOX FDC for 12 Weeks and SOF/VEL for 12 Weeks in DAA-Experienced Adults With Chronic HCV Infection Who Have Not Received an NS5A Inhibitor (POLARIS-4)

Hepatitis C Virus Infection

United States, France, United Kingdom, Germany, Canada, Australia, New Zealand, Puerto Rico
Gilead Sciences

Completed

Safety and Efficacy of SOF/VEL/VOX FDC for 8 Weeks and SOF/VEL for 12 Weeks in Adults Chronic Genotype 3 HCV Infection and Cirrhosis (POLARIS-3)

Hepatitis C Virus Infection

United States, France, United Kingdom, Germany, Australia, Canada, New Zealand, Puerto Rico
National Institute of Allergy and Infectious Diseases...

Completed

Combination Therapy for Chronic Hepatitis C Infection

Hepatitis C, Chronic

United States
Gesynta Pharma AB
CTC Clinical Trial Consultants AB; RISE Research Institutes of Sweden AB

Completed

A Study in Healthy Subjects to Evaluate Pharmacokinetics and Food Effect After Dosing of GS-248

Pharmacokinetic

Sweden
Koya Medical, Inc.

Recruiting

A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of Insight® Pro Device for Evaluating Lymphatic and Venous Disorders (VOLGA) (VOLGA)

Lymphedema | Edema | Venous Insufficiency of Leg | Chronic Venous Insufficiency

United States
University of Houston
University of Oklahoma; Oklahoma State University

Active, not recruiting

Mobile Health and COVID-19

Anxiety Depression

United States
University of South Florida

Completed

Brain Fitness in Parkinson's Disease

Parkinson's Disease

United States
University of California, San Francisco
National Institutes of Health (NIH); National Library of Medicine (NLM)

Recruiting

Multiple Sclerosis Falls Insight Track (MS FIT)

Multiple Sclerosis

United States
Linkoeping University

Not yet recruiting

Cultivating Resilience in Oncology Practice (CROP)

Depressive Symptoms | Childhood Cancer | Anxiety Disorders and Symptoms | Mental Health Issue

Sweden
Virginia Commonwealth University

Completed

Computer-based Cognitive Training for Individuals With Parkinson's Disease

Parkinson's Disease | Mild Cognitive Impairment

United States
East Carolina University
National Institute of Mental Health (NIMH)

Completed

A Public Health Program to Reduce Risk of Antepartum Depression (APD)

Depression

United States
Gilead Sciences

Completed

Efficacy and Safety of Sofosbuvir Containing Regimens for the Treatment of Chronic HCV Infection in Participants With Chronic Genotype 1, 2, 3, or 6 HCV Infection

Chronic Hepatitis C

New Zealand
Gilead Sciences

Terminated

Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of GS-3583 in Participants With Advanced Solid Tumors

Advanced Solid Tumors

United States
Gilead Sciences

Completed

A Phase 1 Study to Evaluate the Pharmacokinetics, Metabolism, and Excretion of GS-5806

RSV Infection

United States
Gilead Sciences

Completed

Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir and Sofosbuvir/Velpatasvir in Adults With Chronic HCV Infection Who Have Not Previously Received Treatment With Direct-Acting Antiviral Therapy (POLARIS-2)

Hepatitis C

United States, France, United Kingdom, Germany, Canada, Australia, New Zealand, Puerto Rico
Gilead Sciences

Completed

Efficacy and Safety of Oral Regimens for the Treatment of Chronic HCV Infection (LEPTON)

Chronic Hepatitis C

New Zealand
Cook Research Incorporated

Completed

Endoscopic Ultrasound-Guided Portosystemic Pressure Gradient Measurements

Liver Diseases | Liver Cirrhosis | Hypertension, Portal

United States, Australia, Hong Kong
Gilead Sciences
Galapagos NV

Completed

Study to Evaluate Safety and Efficacy of Filgotinib and Lanraplenib in Females With Moderately-to-Severely Active Cutaneous Lupus Erythematosus (CLE)

Cutaneous Lupus Erythematosus

United States, Canada
Gilead Sciences

Completed

Study to Evaluate the Safety and Efficacy of Teropavimab and Zinlirvimab in Combination With Lenacapavir (GS-6207) in Virologically Suppressed Adults With HIV-1 Infection

HIV-1 Infection

United States
Gilead Sciences

Completed

Study to Investigate the Efficacy and Safety of Sofosbuvir/Velpatasvir (SOF/VEL) Fixed-Dose Combination (FDC) and Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX ) FDC for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) Infection

Hepatitis C Virus Infection

Korea, Republic of
Gilead Sciences

Terminated

Safety, Pharmacodynamics, Pharmacokinetics, and Efficacy of GS-9901 in Adults With Relapsed or Refractory Follicular Lymphoma, Marginal Zone Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Lymphoma

Follicular Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma

United States
Gilead Sciences

Completed

Study of the Effect of GS-6615 in Subjects With LQT-3

Long QT Syndrome

United States
Gilead Sciences

Terminated

A Phase 1 Study to Characterize the Effect of GS-5737 Enhancement of Mucociliary Clearance (MCC) in Healthy Subjects

Chronic Obstructive Pulmonary Disease | Cystic Fibrosis

United States
Gilead Sciences

Completed

Safety And Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir Fixed-Dose Combination for 12 Weeks in Adults Who Participated in a Prior Gilead-Sponsored HCV Treatment Study

Hepatitis C Virus Infection

Germany, United States, Australia, United Kingdom, Canada, France, New Zealand
NHS Greater Glasgow and Clyde
University of Glasgow

Unknown

Effect of Metacognitive Therapy on Negative Symptoms: a Case Series

Schizophrenia

United Kingdom
University of Minho

Active, not recruiting

Pilot Randomized Controlled Trial of the INSIGHT Program

Deviant Sexual Behavior

Portugal
Queensland University of Technology
Metro South Health Addiction & Mental Health Services

Completed

Psychological Factors In The Treatment Of Bipolar Mood Disorders

Metacognitive Capacities

Australia
University of Wisconsin, Madison

Completed

Well-being and the HM App Pilot (WHAP) Study (WHAP)

Well-being

United States
Gilead Sciences

Terminated

Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Evixapodlin (Formerly GS-4224) in Participants With Advanced Solid Tumors

Advanced Solid Tumors

United States, New Zealand
Gilead Sciences

Completed

Pharmacokinetics of Voxilaprevir in Adults With Normal Hepatic Function and Moderate or Severe Hepatic Impairment

HCV Infection

United States, Germany, New Zealand
Gilead Sciences

Completed

Pharmacokinetics of Voxilaprevir in Adults With Normal Renal Function and Severe Renal Impairment

HCV Infection

United States, New Zealand, Germany
Gilead Sciences

Completed

Pharmacokinetics of Lanraplenib in Adults With Impaired Renal Function

Inflammatory Disease

United States, New Zealand, Germany

Search clinical trials for: Insight GS

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations